ListedSMEDHTL

Docmode Health Technologies Limited

Docmode Health Technologies Limited is a sme IPO raising ₹7 Cr at a fixed price of ₹79 a share. It listed on 2 Feb 2024 and trades at ₹36 today, −54.8% against its issue price of ₹79. It was subscribed 0.00× in total.

79
Issue price
36
Price now
−54.8%
Since issue price
2 Feb 2024
Listed on
0.00×Subscribed (final) · all exchanges

No bids yet

populated partly populated we hold nothing here — the tab says why

How its cohort has done

235 SME issues listed in 2024 that we can price today. This is the group this issue belongs to.

−14.5%
Median return since issue price
55.7%
Now trading below their issue price

Neither figure is a forecast for this issue — they describe what happened to comparable issues. Full cohort analytics →

How the book finished

The category split is the number worth reading, not the total.

QIB0.00×
Non-institutional0.00×
Retail0.00×

QIB: 0.00× their allocation. QIB: 0.00×.

See the full split, sub-category by sub-category →

What we hold for this issue

Stated up front on every issue, so a sparse page reads as a fact about the source rather than a broken one.

Category split — who bidQIB, non-institutional and retail, with sub-splits
How demand built over timeNo subscription figure was published
Price-point demand curveLive only — NSE stops serving this once bidding closes
Lead managers and registrar1 bank
Official documents1 document
Performance since listingComputed from our own daily closes

What happens when

25 Jan 2024Bidding opens
30 Jan 2024Bidding closes
31 Jan 2024Allotment finalised — you find out what you got
1 Feb 2024Money refunded to unsuccessful bidders
2 Feb 2024Shares list and start trading

Track DOCMODE HEALTH TECH LTD

Results, orders, board decisions and every other filing — summarised and sent to your WhatsApp the minute they are out.

Open the company page

Figures are as published by the exchanges and the issuer’s prospectus. MarketPing publishes facts, comparisons and history only — nothing here is a recommendation to apply to this issue, and we do not publish grey market premium.